Deficiency of a Glycogen Synthase-associated Protein, Epm2aip1, Causes Decreased Glycogen Synthesis and Hepatic Insulin Resistance

Julie Turnbull, Erica Tiberia, Sandra Pereira, Xiaochu Zhao, Nela Pencea, Anne L. Wheeler, Wen Yu, Alexander Ivovic, Taline Naranian, Nyrie Israelian,

Journal of Biological Chemistry · 2013 · 22 citations · 42 references

DOIFull text

Open access

Concepts

Abstract

Glycogen synthesis is a major component of the insulin response, and defective glycogen synthesis is a major portion of insulin resistance. Insulin regulates glycogen synthase (GS) through incompletely defined pathways that activate the enzyme through dephosphorylation and, more potently, allosteric activation. We identify Epm2aip1 as a GS-associated protein. We show that the absence of Epm2aip1 in mice impairs allosteric activation of GS by glucose 6-phosphate, decreases hepatic glycogen synthesis, increases liver fat, causes hepatic insulin resistance, and protects against age-related obesity. Our work identifies a novel GS-associated GS activity-modulating component of insulin resistance.

References

42